TABLE 1.
Genetic and phenotypic properties of CMRSA isolates from Australia and NZa
| Isolate | Antimicrobial properties | Plasmid profileb | CHEF pattern | ST | MLST allelic profile | CC | ccr gene complex | mec complex | SCCmec type | Presence (+) or absence (−) of pvl genes | spa type | spa motif | Origin (reference) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WBG8287 | Bla, EI, F, C | 19.6, 2 | B1 | 1 | 1-1-1-1-1-1-1 | 1 | 2 | B | IVa | − | 35 | U1-J1-F1-K1-B1-P1-E1 | WA (29) |
| WBG8873 | Bla, EI, T, F, C | 19.6, 2 | B2 | 1 | 1-1-1-1-1-1-1 | 1 | 2 | B | IVa | − | 35 | U1-J1-F1-K1-B1-P1-E1 | SA (21) |
| WBG10200 | Bla, F, C | 19.6 | B3 | 1 | 1-1-1-1-1-1-1 | 1 | 2 | B | IVa | − | 35 | U1-J1-F1-K1-B1-P1-E1 | VIC (21) |
| WBG8366 | Bla, EI, C | 19.6, 2 | C1 | 255 | 22-3-14-23-12-53-31 | 298 | 2 | B | IVa | − | 9 | U1-G1-F1-M1-E1-E1-B1-P1-B1 | WA (29) |
| WBG8900 | Bla, EI, C | 19.6, 2 | C2 | 257 | 22-1-14-19-12-53-31 | 298 | 2 | B | IVa | − | ND | SA (21) | |
| WBG8378 | Bla, EI, C | 21.6, 2 | D1 | 5 | 1-4-1-4-12-1-10 | 5 | 2 | B | IVa | − | 2 | T1-J1-M1-B1-M1-D1-M1-G1-M1-K1 | WA (29) |
| WBG10201 | Bla, C | 32 | D2 | 5 | 1-4-1-4-12-1-10 | 5 | 2 | B | IVa | − | 2 | T1-J1-M1-B1-M1-D1-M1-G1-M1-K1 | VIC (21) |
| WBG8404 | Bla, C, As | 24.5 | E | 45 | 10-14-8-6-10-3-2 | 45 | 5 | B1 | New | − | 6 | A2-A1-K1-B1-E1-K1-B1-K1-B1 | WA (21, 29) |
| WBG7583 | Bla, T, C | 28.6 | A | 8 | 3-3-1-1-4-4-3 | 8 | 2 | B | IVa | − | 1 | Y1-H1-G1-F1-M1-B1-Q1-B1-L1-O1 | WA (56) |
| WBG8897 | Bla, Ci, C | None | H | 22 | 7-6-1-5-8-8-6 | 22 | 2 | B | IVa | − | 382 | T1-J1-J1-E1-J1-N1-F2-M1-N1-F2-M1-O1- M1-O1-K1-R1 | SA (21) |
| WBG9087 | Bla, EI, C | 25.6, 2 | F | 75 | 36-3-43-34-39-52-49 | new1 | 2 | B | IVa | − | 401 | Q2-N1-M1-M1-M1-J1-M1-M1-J1-M1-L1 | NT (21) |
| WBG9093 | Bla, EI, C | 19.6, 2 | G | 258 | 36-3-43-1-39-52-49 | new1 | 2 | B | IV | − | 400 | Q2-J1-J1-M1-M1-M1-J1-J1-J1-M1-K1 | NT (21) |
| WSPP-1b | Bla, C | 25 | J1 | 30 | 2-2-2-2-6-3-2 | 30 | 2 | B | IVa | + | 19 | X1-K1-A1-K1-A1-O1-M1-Q1 | NSW (9) |
| WSPP-1a | Bla, T, C, Eb | 43, 8, 4.4 | J1 | 30 | 2-2-2-2-6-3-2 | 30 | 2 | B | IVa | + | ND | NZ (1) | |
| WSPP-2 | Bla, C | 25 | J2 | 30 | 2-2-2-2-6-3-2 | 30 | 2 | B | IVa | + | 19 | X1-K1-A1-K1-A1-O1-M1-Q1 | NZ (1) |
| WBG10198 | Bla, C, As | 36 | J3 | 30 | 2-2-2-2-6-3-2 | 30 | 5 | E | New | − | 33 | W1-G1-K1-A1-K1-A1-O1-M1-Q1-Q1 | VIC (21) |
a
Abbreviations: As, arsenate resistance; Bla, Bla production; C, cadmium resistance; Ci, ciprofloxacin resistance; EI, inducible erythromycin resistance; Eb, ethidium bromide resistance; F, fusidic acid resistance; Hg, mercury resistance; ND, not determined; T, tetracycline resistance.
b
Plasmid sizes, when given, are in kilobases.